Q--NGS services to support clinical research

The National Institutes of Health (NIH) Office of the Director, Office of Acquisitions, is seeking Next-Generation Sequencing (NGS) services to support clinical research through solicitation number 75N98026Q00369. This requirement is being conducted as a competitive combined synopsis/solicitation for commercial services under the authority of FAR 12.603 and is not expected to exceed the simplified acquisition threshold. The government intends to award a firm-fixed-price purchase order to the responsible offeror whose proposal provides the best value to the government.

This acquisition is classified under NAICS 621511 Medical Laboratories and PSC Q301 Medical- Laboratory Testing. The opportunity is designated as a small business set-aside (SBA), with a corresponding small business size standard of $41.5 million. The solicitation and its incorporated provisions and clauses are governed by Federal Acquisition Circular 2026-01, effective March 13, 2026. Nicholas S. Capobianco is the point of contact for this requirement.

The response deadline for this solicitation is May 29, 2026. Documentation associated with this notice includes five attachments: the original solicitation, a combined synopsis/solicitation document, and three subsequent amendments, the latest of which was posted on May 22, 2026. Proposals are being requested as part of this announcement, and no separate written solicitation will be issued.